Adult Asthma Report 5 Coles Lane, Oakington, Cambridge, CB24 3BA.

Slides:



Advertisements
Similar presentations
Medication Management
Advertisements

What is an asthma registry? n A list of patients with asthma n A source of data for asthma management  individual patient level  individual provider.
2012 UPDATE. What guidelines do we have available to follow for asthma 1) Asthma GP monitoring Guideline 2) Asthma Diagnosis Guideline 3) Acute asthma.
Nabeela Bari Savitha Pushparajah GP respiratory leads.
Global Initiative for Asthma (GINA) What’s new in GINA 2015?
ELJF-CLINICAL v3.04 Quick 6-step tutorial in under 5 minutes.
Managing asthma & Inhaler devices for respiratory disease.
Clearing the Airways: Innovation in Asthma & Allergy Treatments Chair: Alan Kaplan MD CCFP(EM) FCFP Chair, FPAGC.
Inhaler technique is it important?. Compton et al (2006) Review of evidence from 6 European countries ( Spain, Italy, France, Germany, Netherlands, UK)
22/06/2011.  Asthma – an introduction (Vanessa)  Diagnosis and management of chronic asthma in line with current BTS guidelines (Dr Lowery)  3 x Case.
1 British Guideline on the Management of Asthma BTS/SIGN British Guideline on the Management of Asthma, May 2008 Introduction Diagnosis Non-pharmacological.
Asthma Management Fine Tuning  Maximum control with minimum medication  Start with mild asthma and work up the scale (BTS/SIGN 2004)
NICE quality standard for COPD Craig Grime Technical Analyst Quality Standards NICE
Bronchial Asthma  Definition  Patho-physiology  Diagnosis  Management.
© IPCRG June 2006 Asthma Control Tools User Guide Summary April 2007 This summary should be read in conjunction with the users’ guide found at
Assessing Control & Adjusting Therapy in Youths > 12 Years of Age & Adults *ACQ values of 0.76–1.4 are indeterminate regarding well-controlled asthma.
COPD Diagnosis & Management Anil Ramineni Specialist Respiratory Physiotherapist Community Respiratory Team.
DDES CCG COPD Project 01/05/15 Dr Dilys Waller Respiratory Nurses - Susan Evison Caroline Blackburn Nichola Lowe Karen Beedle.
Component 4 Medications. Key Points - Medications  2 general classes: – Long-term control medications – Quick-Relief medications  Controller medications:
History Taking Zinc code: UKACL1878ea Date of preparation May 2015 AstraZeneca provided funding & reviewed for technical accuracy.
ASTHMA MANAGEMENT AND PREVENTION PREFACE Asthma affects an estimated 300 million individuals worldwide. Serious global health problem affecting all age.
Asthma Guidelines, Diagnosis and Management Alison Hughes Respiratory Specialist Nurse Solent NHS Trust.
© Global Initiative for Asthma GINA Global Strategy for Asthma Management and Prevention 2015 This slide set is restricted for academic and educational.
Wendy Pigg Practice support Pharmacist/Independent Prescriber
Areas to cover Analysis of information Recruitment Review.
Prescribing for patients with COPD Evidence Update Emma Blanden- Pharmacist.
PICH Childhood Asthma project Bina Chauhan Locum GP 4/5/16.
PULMONARY REHABILITATION.
Asthma Kills Sophie Toor
Wales Primary Care COPD Audit
Prison Pain Formulary Background Denise Farmer April 2016.
Medicines Optimisation
Jessica Case study.
Treating Mild Asthma: what’s in it for the patient? Regien Kievits,
Emergency Department Asthma Care Pathway (EDACP)
Judy Phillips, DNP, FNP-BC, AOCN Cancer Care of Western North Carolina
Assessment and Monitoring Asthma and Clinical Action Plan
MODERATE & ACUTE SEVERE ASTHMA
Challenges in recruiting primary care doctors for a randomized controlled trial to study change in prescription practices due to our educational intervention.
Dr Mohamed Ouda MRCGP 1-Reason for choice of audit 3-Standards set
Research where it is most needed National Respiratory Strategy
Child Asthma Report 5 Coles Lane, Oakington, Cambridge, CB24 3BA.
Virginia Commonwealth University
The Modern Management of Asthma: Getting it right
COPD Report 5 Coles Lane, Oakington, Cambridge, CB24 3BA.
Asthma Yardstick Annals of Allergy, Asthma & Immunology
Medical care and self-management support for asthma in primary care: a comparison between France and the United Kingdom A.Dima, E. van Ganse, H. Le Cloarec,
Monitoring asthma in primary care
Patterns of asthma medications prescriptions among adult patients in the chest and accident and emergency units of a tertiary health care facility in Uganda.
Global Initiative for Asthma (GINA) What’s new in GINA 2015?
Treatment Strategies in Mild to Moderate COPD
Small-particle Inhaled Corticosteroid as First-line or Step-up Controller Therapy in Childhood Asthma  Willem M.C. van Aalderen, MD, PhD, Jonathan Grigg,
The Role of the Primary Care Physician in Helping Adolescent and Adult Patients Improve Asthma Control  Barbara P. Yawn, MD, MSc  Mayo Clinic Proceedings 
Medicines Optimisation
Asthma Annual Reviews Hetal Dhruve Presented by Anh Vu
Rhematoid Rthritis Respiratory disorders
Severe Asthma in Primary Care: Identification and Management
The Modern Management of Asthma: Getting it right Part 2
12 months before treatment 12 months after treatment
Dr Mark L Levy’s EMIS Asthma Template
Childhood Asthma : Lessons still to be learnt
Global Initiative for Asthma (GINA) What’s new in GINA 2015?
West Essex Frailty Pathway: COPD
Michael E. Wechsler, MD  Mayo Clinic Proceedings 
Inhaled Antibiotics for Patients With CF in the Era of CFTR Modulators
Integration of community pharmacy with PCNs
Asthma Education for Families and HCPs
Introduction Project At Crown Street Surgery:
D94- COPD: EPIDEMIOLOGY AND THERAPY
Nottingham City Care Integrated Respiratory Service and Home Oxygen Service Zoe Styles Senior Physiotherapist.
Presentation transcript:

Adult Asthma Report 5 Coles Lane, Oakington, Cambridge, CB24 3BA

The adult asthma report only concerns patients aged ≥ 18 years Practice Overview The adult asthma report only concerns patients aged ≥ 18 years Asthma Patient: asthma QOF diagnosis code & no asthma resolved code & issued respiratory therapy in last 2 years Page 1

Contents Patient Demographics Asthma Diagnosis Asthma Control Asthma Management Risk and Exacerbations Adherence and Asthma Reviews Recommendations Page 2

Age Distribution Co-morbidities Smoking Status Patient Demographics Contents Patient Demographics Age Distribution Co-morbidities Smoking Status Asthma Diagnosis Asthma Control Asthma Management Risk and Exacerbations Adherence and Asthma Reviews Recommendations Page 3

The adult asthma report only concerns patients aged ≥ 18 years Patient Demographics Age Distribution The adult asthma report only concerns patients aged ≥ 18 years Page 4

Co-morbidities Patient Demographics Page 5 Rhinitis: Read code entry in last 2 years or nasal steroid therapy in last year GERD, Depression/Anxiety: Read code entry in last 2 years Page 5

Smoking Status Patient Demographics Page 6 Smoking status is obtained from patient questionnaires where available or from routine practice data Page 6

Confirming Asthma Diagnosis Potentially Undiagnosed Patients Contents Patient Demographics Asthma Diagnosis Confirming Asthma Diagnosis Potentially Undiagnosed Patients Asthma Control Asthma Management Risk and Exacerbations Adherence and Asthma Reviews Recommendations Page 7

Confirming Asthma Diagnosis Asthma Diagnosis: asthma QOF diagnosis code Excluding Patients ≤ age 7 years: QOF AST002 Page 8

Potentially Undiagnosed Patients Asthma Diagnosis Potentially Undiagnosed Patients LRTIs: measured as occurrence of 3 or more LRTIs in last 2 years Asthma Diagnosis: asthma QOF diagnosis code Page 9

Control Status from RCP Data, SABA use, etc. Contents Patient Demographics Asthma Diagnosis Asthma Control Control Status from RCP Data, SABA use, etc. Smoking, Rhinitis and Asthma Control Asthma Management Risk and Exacerbations Adherence and Asthma Reviews Recommendations Page 10

Measuring Asthma Control Information from three sources is used to assess patients’ asthma GINA control score* and other measures of asthma control: Practice recorded data from RCP3 questions, ACT questions, reliever use and PEFR. Data from patient questionnaire responses: RCP3 questions, reliever use, etc. Quantity of SABA prescriptions, which can be used as proxy measure of asthma control. Global INitiative for Asthma (GINA) control score can be calculated from RCP3 questions responses, reliever use and lung function data Page 11

Asthma Control Status: RCP Data* RCP data is obtained from patient questionnaires where available or from routine practice data Page 12

Asthma Control Status: SABA as Proxy* Where RCP Data Unknown Quantity of short acting bronchodilators issued is used as proxy measure of asthma control where RCP data is not available Page 13

Smoking and Asthma Control* OPC Service Control status is based on RCP data obtained from patient questionnaires where available or from routine practice data Page 14

Rhinitis and Asthma Control* OPC Service Control status is based on RCP data obtained from patient questionnaires where available or from routine practice data Page 15

Management by BTS Steps Contents Patient Demographics Asthma Diagnosis Asthma Control Asthma Management Management by BTS Steps Risk and Exacerbations Adherence and Asthma Reviews Recommendations Page 16

BTS/SIGN Step Guidelines: Adults Asthma Management BTS/SIGN Step Guidelines: Adults Page 17

Management by BTS Step: Adults Asthma Management Management by BTS Step: Adults Page 18

Asthma Control by BTS Step: RCP Data* Asthma Management Asthma Control by BTS Step: RCP Data* OPC Service Control status is based on RCP data obtained from patient questionnaires where available or from routine practice data Page 19

Asthma Control by BTS Step: SABA Proxy* Asthma Management Asthma Control by BTS Step: SABA Proxy* OPC Service Quantity of short acting bronchodilators issued is used as proxy measure of asthma control where RCP data is not available Page 20

High Risk Patients Exacerbations Patient Demographics Asthma Diagnosis Contents Patient Demographics Asthma Diagnosis Asthma Control Asthma Management Risk and Exacerbations High Risk Patients Exacerbations Adherence and Asthma Reviews Recommendations Page 21

High Risk Asthma Patients Risk and Exacerbations High Risk Asthma Patients High Risk: 2 or more exacerbations per year Very High Risk: 2 or more exacerbations per year & at BTS Step 4 or 5 Page 22

Exacerbation* by BTS Step Risk and Exacerbations Exacerbation* by BTS Step OPC Service Exacerbations: exacerbation Read code entry or patient reported exacerbation & hospitalisations & number of courses of oral steroids in last 12 months Page 23

Acute Oral Steroid Use* by BTS Step Risk and Exacerbations Acute Oral Steroid Use* by BTS Step OPC Service Courses of acute oral steroids issued in the last 12 months Page 24

Adherence to Inhaled Steroids Inhaler Technique Asthma Reviews Contents Patient Demographics Asthma Diagnosis Asthma Control Asthma Management Risk and Exacerbations Adherence and Asthma Reviews Adherence to Inhaled Steroids Inhaler Technique Asthma Reviews Recommendations Page 25

Adherence to Inhaled Steroids* Adherence and Asthma Reviews Adherence to Inhaled Steroids* Number of scripts in last 1 year Number of scripts expected based on prescribed dosage Adherence = X 100 Inhaled steroids include ICS and combination therapies Page 26

Inhaler Technique* and Asthma Control Status Adherence and Asthma Reviews Inhaler Technique* and Asthma Control Status OPC Service Inhaler technique review provided in last 12 months and recorded by Read code entry Page 27

Asthma Reviews and Self-Management Plans* Adherence and Asthma Reviews Asthma Reviews and Self-Management Plans* Asthma reviews and self-management plans provided in last 12 months and recorded by Read code entry Page 28

Asthma Reviews* by BTS Step Adherence and Asthma Reviews Asthma Reviews* by BTS Step Asthma reviews provided in last 12 months and recorded by Read code entry Page 29

Therapy Recommendations Management Recommendations Contents Patient Demographics Asthma Diagnosis Asthma Control Asthma Management Risk and Exacerbations Adherence and Asthma Reviews Recommendations Therapy Recommendations Management Recommendations Page 30

PLEASE NOTE Recommendations The practice report recommendations have been grouped into ‘Therapy Recommendations’ and ‘Management Recommendations’. Please consider both groups of recommendations together, as a holistic approach is vital for effective patient care and optimising patient outcomes. Patients covered within each recommendation and the patient questionnaire responses can be viewed on your asthma patient level reports, through the OPC Tools application on your practice computer. Please refer to the ‘Viewing Patient Reports’ user-guide to assist you in this regard. Alternatively, please contact the OPC service delivery team for assistance. Optimum Patient Care 5 Coles Lane, Oakington, Cambridge, CB24 3BA Tel: 01223 967 855 email: services@optimumpatientcare.org Page 31

Therapy Recommendations Please review patient adherence/concordance and inhaler technique before stepping up therapy Adapted from BTS/SIGN and Global Initiative for Asthma (GINA) guidelines Page 32

Your Practice Therapy Recommendations Page 33

Management Recommendations Adapted from BTS/SIGN and Global Initiative for Asthma (GINA) guidelines Page 34

Your Practice Management Recommendations Page 35